GSK, Sanofi, Haleon shares stabilise after Zantac slump
Shares in GSK, Sanofi and Haleon began to stabilise today after the companies said that nothing material had changed regarding US litigation focused on heartburn drug Zantac.
Business
• 12 Aug 22
